Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

2.89USD
19 Dec 2014
Price Change (% chg)

$0.04 (+1.40%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.90
Day's Low
$2.79
Volume
208,182
Avg. Vol
942,827
52-wk High
$3.49
52-wk Low
$1.70

CPRX.O

Chart for CPRX.O

About

Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy. As of December 31, 2011,... (more)

Overall

Beta: 0.79
Market Cap (Mil.): $204.59
Shares Outstanding (Mil.): 69.12
Dividend: --
Yield (%): --

Financials

  CPRX.O Industry Sector
P/E (TTM): -- 159.35 38.84
EPS (TTM): -0.22 -- --
ROI: -40.78 -0.82 18.26
ROE: -45.53 -1.98 19.12
Search Stocks

UPDATE 1-Catalyst Pharma's lead drug succeeds in late-stage study

Sept 29 - Catalyst Pharmaceutical Partners Inc said its lead drug was found superior in treating symptoms associated with a rare autoimmune disorder, compared with a placebo.

29 Sep 2014

BRIEF-Catalyst Pharmaceuticals announces positive top-line PHASE 3 data from Firdapse clinical trial

* Announces positive top-line PHASE 3 data from Firdapse clinical trial in patients with lambert-eaton myasthenic syndrome

29 Sep 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks